2016
DOI: 10.1177/0956462416653559
|View full text |Cite
|
Sign up to set email alerts
|

Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors – A retrospective cohort study

Abstract: Aim: This retrospective cohort study analyzes the impact of possible risk factors on the survival chance of patients with Cryptococcal meningitis (CM). These factors include the patient's socioeconomic background, age, gender, presenting symptoms, comorbidities, laboratory findings and, in particular, non-adherence versus adherence to therapy.Methods: Data was collected from all adult patients admitted to Kalafong Hospital with laboratory confirmed CM over a period of 24 months. We analyzed the data by the pre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 18 publications
(27 reference statements)
1
5
0
Order By: Relevance
“…In 10% (4/41) of included studies, the period of observation began prior to 2000. Seventeen countries were represented, with greatest representation from South Africa (14 studies) [34,[37][38][39][40][41][42][43][44][45][46][47][48][49], Ethiopia (three studies) [50][51][52] and Uganda (three studies) [53][54][55]; other countries had two or fewer studies [11,35,36,[56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74]. Amphotericin B-based induction therapy (with or without fluconazole) was the predominant induction regimen in 16 studies, fluconazole in 13 studies, and a mix of treatments (45% fluconazole and 43% amphotericin B) in one study [44], with antifungal regimens not specified in 11 studies.…”
Section: Overall Search Findingsmentioning
confidence: 99%
“…In 10% (4/41) of included studies, the period of observation began prior to 2000. Seventeen countries were represented, with greatest representation from South Africa (14 studies) [34,[37][38][39][40][41][42][43][44][45][46][47][48][49], Ethiopia (three studies) [50][51][52] and Uganda (three studies) [53][54][55]; other countries had two or fewer studies [11,35,36,[56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74]. Amphotericin B-based induction therapy (with or without fluconazole) was the predominant induction regimen in 16 studies, fluconazole in 13 studies, and a mix of treatments (45% fluconazole and 43% amphotericin B) in one study [44], with antifungal regimens not specified in 11 studies.…”
Section: Overall Search Findingsmentioning
confidence: 99%
“…There is sound data that raised intracranial pressure correlates with higher mortality and international and national guidelines support aggressive management if the baseline opening CSF pressure is raised. 20 Our own data showed an increased mortality in those patients that were admitted with features consistent with high CSF pressures 7 and the five patients with communicating hydrocephalus are probably part of this subgroup with poor prognosis. Unfortunately, as this was a retrospective study, opening pressures were mostly not documented and, therefore, we cannot compare and correlate the pressures with the imaging.…”
Section: Discussionmentioning
confidence: 79%
“…The overall mortality in the patients that underwent CT brain imaging was 33.3%, hence, very similar to the in-patient mortality in the total cohort of patients with cryptococcal meningitis (31%). 7 In the group with cryptococcal-related changes on imaging, the mortality was higher (50%) and a small subgroup of patients with hydrocephalus showed a 100% mortality ( n = 5). The patients with normal cerebral imaging and the group of patients that had cerebral atrophy and no other pathological findings, had lower mortalities at 25% and 16.7%, respectively.…”
Section: Resultsmentioning
confidence: 91%
See 1 more Smart Citation
“…[1][2][3][4] In sub-Saharan Africa, the human immunodeficiency virus (HIV) pandemic increased the risk of meningitis in seropositive adults, with Cryptococcus neoformans and Mycobacterium tuberculosis emerging as prominent pathogens. [5][6][7][8] Symptoms of meningitis include headache, fever, altered mental status and neck stiffness, but are non-specific. 9 Clinicians working in high HIV prevalence settings need to maintain a high level of suspicion for meningitis, and investigate when the presenting symptoms suggest the diagnosis.…”
Section: Introductionmentioning
confidence: 99%